Results 71 to 80 of about 1,936 (153)

In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii

open access: yesScientific Reports, 2022
We investigated the in vitro activity of various antimicrobial combinations against carbapenem-resistant Acinetobacter baumannii (CRAB) isolates. The in vitro activity of six two-drug combinations against CRAB isolates collected from the blood samples of
Yong Guk Ju   +5 more
doaj   +1 more source

Relapsing Salmonella Meningitis in an Infant: A Case Report and Review of the Literature

open access: yesCase Reports in Pediatrics, Volume 2026, Issue 1, 2026.
Accurate diagnosis of bacterial meningitis is critical, particularly in young febrile infants. Although commercially available multiplex PCR assays enable rapid pathogen detection, these typically do not include Salmonella spp. or other Enterobacteriaceae, which may result in missed diagnoses and/or inappropriate treatment duration.
Sonia Alexiadou   +7 more
wiley   +1 more source

Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing

open access: yes, 2020
OBJECTIVES: To investigate the influence of continuous renal replacement therapy (CRRT) intensity on the clearance of ceftolozane/tazobactam in critical care patients, and to evaluate if the reported doses would achieve an optimal pharmacokinetic ...
Gatti, Milo   +9 more
core   +1 more source

Acquisition of extended-spectrum β-lactamase GES-6 leading to resistance to ceftolozane-tazobactam combination in Pseudomonas aeruginosa [PDF]

open access: yes, 2019
A clinical Pseudomonas aeruginosa isolate resistant to all β-lactams, including ceftolozane-tazobactam and carbapenems, was recovered. It belonged to sequence type 235 and produced the extended-spectrum β-lactamase (ESBL) GES-6 differing from GES-1 by
Dubois, Véronique   +18 more
core   +1 more source

Ceftolozane/Tazobactam for Complex and Resistant Infections: Systematic Reviews of Comparative Efficacy Studies

open access: yesAntibiotics
Introduction: The emergence and spread of multidrug-resistant infections has resulted in significant clinical and economic burdens. To address these infections, novel therapy combinations are needed.
Ignacio Martin-Loeches   +7 more
doaj   +1 more source

When the Medium Skews the Message: Commercial Mueller–Hinton Agar Media and Their Effect on Antibiogram Results of Imipenem, Ciprofloxacin, and Gentamicin Against Standard and Clinical Strains of Pseudomonas aeruginosa

open access: yesInternational Journal of Microbiology, Volume 2026, Issue 1, 2026.
Accurate antimicrobial susceptibility testing (AST) is essential for guiding effective therapy and monitoring antibiotic resistance, particularly for Pseudomonas aeruginosa, a pathogen noted for its intrinsic and adaptive resistance mechanisms. Mueller–Hinton agar (MHA) is the standard medium for AST; however, variations in its composition among ...
Amir Reza Abdollahi   +6 more
wiley   +1 more source

Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam

open access: yes, 2017
Ceftolozane/tazobactam is a novel fifth-generation cephalosporin β-lactamase combination with activity against extended-spectrum β-lactamases-producing enterobacteriaceae, and multidrug resistant Pseudomonas aeruginosa.
Marta Bodro   +4 more
core   +1 more source

Molecular Characterization and Antibiotic Resistance of Broad‐Spectrum β‐Lactamase‐Producing Enterobacterales in Urinary Tract Infections in Libreville, Gabon

open access: yesInternational Journal of Microbiology, Volume 2026, Issue 1, 2026.
Background The effectiveness of antibiotic therapy for urogenital tract infections (UTIs) is increasingly compromised by the global dissemination of extended‐spectrum β‐lactamase‐producing Enterobacterales (ESβL‐En). This study aimed to assess the involvement of broad‐spectrum β‐lactamase‐producing Enterobacterales (BSβL‐En) in UTIs and to establish ...
Jean Fabrice Yala   +7 more
wiley   +1 more source

A Review of β‐Lactamase Inhibitors in Clinical Use and Development: Mechanisms, Spectrum, and Therapeutic Applications

open access: yesInternational Journal of Microbiology, Volume 2026, Issue 1, 2026.
β‐Lactam antibiotics have long served as a cornerstone for treating bacterial infections. However, their widespread and often indiscriminate use has fueled the emergence of multidrug‐resistant Gram‐negative pathogens, primarily through the production and dissemination of β‐lactamase enzymes.
Mohammad Javad Roustaye Gourabi   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy